Share
USER HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.
Search for ""
Search for ""
CytoSorbents

Voices around the world

Our work supports patients and their families during challenging care situations, supports healthcare professionals seeking options in complex scenarios, and contributes to the ongoing development of blood purification science. Here are some global examples illustrating our experience and collaborations.

Dr. Guadalupe Castillo

CytoSorb definetely gives us the opportunity to prevent the patient from developing complications or facing a more serious situation, which could lead to death.

Search for Voices

About CytoSorbents Cardiovascular Critical Care Kidney Liver
Critical Care
Dr. Guadalupe Castillo
Panama City, Panama

CytoSorb definetely gives us the opportunity to prevent the patient from developing complications or facing a more serious situation, which could lead to death.

Critical Care
Dr. Andres Salazar
Tunja, Colombia

Saving lives means a commitment not only to our region, but to all the people around us.

Cardiovascular
Dr. Helmut Mair
Munich, Germany

We had no bleeding problems whatsoever. The adsorber was in use throughout the operation. It worked really well. We believe in this product.

Critical Care
Dr. Lena Candels
Aachen, Germany

We do everything we can. The patient is young, has a chance, let’s start the adsorber. Often the patient gets better and you can think about next steps.

Critical Care
Dr. David Ballesteros
Popayán, Colombia

Without CytoSorb it would have been impossible to remove molecules of high molecular weight and strong protein binding.

Critical Care
Dr. Andres Salazar
Tunja, Colombia

It is satisfactory to help a patient and remove all those inflammatory substances. It provided us with the opportunity to avoid mechanical ventilation.

Critical Care
Peter Dautzenberg
Aachen, Germany

We achieved great success. The values dropped fast. When you see that you can achieve impressive results by relatively simple means, it has real impact on you.

Critical Care
Dr. Giorgio Berlot
Trieste, Italy

Treat the patient as soon as possible within 48 hours and as much as possible. The more and earlier you treat, the better the outcome of the patient.

Critical Care
Dr. Euclides Cruz
Pereira, Colombia

I remember a 23-year old man, who ingested a toxic substance: paraquat. No antidote, mortality is approx. 90%. CytoSorb worked really well, he survived.

Critical Care
Dr. Katerina Negri
Milan, Italy

I decided to add CytoSorb. The next morning, the patient was immediately weaning off pressers, and it was a real game changer.

Critical Care
Prof. Peter Pickkers
Nijmegan, The Netherlands

The treatment with the CytoSorb® adsorber does reduce circulating concentrations at day one.

Critical Care
Prof. Olfa Hamzaoui
Reims, France

Prof. Hamzaoui shares a compelling summary of key highlights, clinical insights, and the growing role of CytoSorb Therapy in critical care.

Critical Care Liver
Dr. Pedro Túlio Rocha
Rio de Janeiro, Brazil

Sometimes the patient dies before the transplant. The CytoSorb treatment helped her to get the time she needed to get the organ.

Liver
Prof. Dr. Ali Canbay
Bochum, Germany

I use CytoSorb simply to get patients out of liver failure.

Critical Care
Prof. Dorel Sandec
Timisoara, Romania

We treated more than 75 patients with CytoSorb® because we realized, we feel, we see, we measure a significant effect on the evolution of the patient.

Cardiovascular
Dr. Serdar Gunaydin
Ankara, Turkey

One of the most important indications for us to use CytoSorb® in is cardiac surgery, as it has also been cited in many guidelines.

Critical Care
Dr. Philipp Hohlstein
Aachen, Germany

We use the adsorber regularly and have really good experience with it in every day clinical practice.

Critical Care
Dr. Guadalupe Castillo
Panama City, Panama

I think CytoSorb is definitely an additional tool that we can use to save more lives.

Critical Care Liver
Dr. Marianna di Feliciantonio
Milan, Italy

We improved his state and we helped this patient to the transplantation, and we used the CytoSorb like a bridge for transplant.

Critical Care
Dr. Sandra Pena Salazar
San Salvador, El Salvador

In coronary patients with low ejection fraction, endocarditis, we use it almost routinely. It has been a valuable support. We have seen shorter hospital stays.

Critical Care
Prof. Dr. Alexander Koch
Aachen, Germany

We used CytoSorb since there was no alterntive really, either the patient dies in thew acute setting or we use the innovative process in an attempt to save him.

Critical Care
Dr. Klaus Kogelmann
Leer, Germany

Those who were treated early and based on short change intervals benefited the most from the therapy.

Cardiovascular
Prof. Arjan Ruhrparwar
Hanover, Germany

This product is very interesting for most clinicians. You can do something with it that you could not achieve with any drug.

Critical Care
Dr. David Castillo Bustamante
San Salvador, El Salvador

We used CytoSorb in three cases of severe dengue: we monitored the inflammatory response throughout the course of the therapy. We have had very good result.

Critical Care
Janine Emmerich
Bad Bevensen, Germany

The patient had a really long medical course and the weaning took long as well. But after all this, he came by to visit us. It was a striking moment.

Critical Care Kidney
Dr. Alessandra Lombardo
Legnano, Italy

I remember this case because it was a rhabdo like we have never seen before. And I remember CytoSorb was a very
big part of his treatment.

Cardiovascular
Prof. Dr. Markus Krane
Munich, Germany

Post-operative bleeding and related post-operative blood transfusion, that are usually necessary, are reduced. And that’s a better outcome for the patient.

Critical Care
Dr. Daniela Nickoleit-Bitzenberger
Dortmund, Germany

Without CytoSorb, things would have been very dicey. We would probably have had to admit him to a special clinic for liver deseases.

Cardiovascular
Dr. Lars-Uwe Kühne
Hamburg, Germany

Use it at the right time, don’t hesitate too long, and it will work. When someone is critically ill, it is the game changer.

Critical Care Liver
Dr. Pavlo Prylutzki
Minsk, Belarus

In these patients, it could give us one or two days to win time and to give the liver some time to start working.

Critical Care
Dr. Ingrid Ausserhofer-Blaschitz
Graz, Austria

We ran CytoSorb in the dialysis machine and we were able to get the inflamatory parameters under really good control.

Critical Care
Prof. Olfa Hamzaoui
Reims, France

To be honest with you, we are not using CytoSorb at the moment. And I think that it is just a lack of knowledge about the technique.

Cardiovascular
Prof. Dr. Yeong-Hoon Choi
Bad Nauheim, Germany

We were able to decrease the need for circulatory supporting medications accordingly, very, very quickly to a tolerable level.

Liver
Dr. Kristian Mnich
Olten, Switzerland

I can speak about a case where the patient had acute chronic liver failure in the context of known liver cirrhosis.

Critical Care
Daniela Müller
Dresden, Germany

We were able to reduce the circulation-supporting medication and we saw decreasing lacatate levels and the patient was more stable.

Critical Care
Marco Reinhard
Dresden, Germany

We can always tell, if it is working because we can measure it.

Critical Care
Dr. Gerd Klinkmann
Rostock, Germany

What we have seen, however, is that, by using the adsorber, we were able to reduce the hyperinflammation significantly and quickly to help the patient.

Cardiovascular
Prof. Dr. Jurij Kalisnik
Klagenfurt, Austria

So for me, if the indication is right, this supportive therapy helps a lot.

Cardiovascular
Prof. em. Heinz Jakob
Essen, Germany

Listen to Dr. Heinz Jakob talk about his experiences with CytoSorb Therapy.

About CytoSorbents
Prof. Jean Louis Vincent
Brussels, Belgium

I would like to send my congratulations on the 10th anniversary of CytoSorb®. It is great how you have created a new way of blood purification therapy.

Kidney
Dr. Filipo Aucella
San Giovanni, Italy

When we started to use CytoSorb®, we were very impressed by the rapid decrease of myoglobin concentrations, and the renal damage also improved very rapidly.

Critical Care
Dr. Tobias Hübner
Münsterlingen, Switzerland

The reason for us to use CytoSorb in the ICU was the lack of treatment options. We never had anything in sepsis, and CytoSorb® is the new star on the horizon.

Critical Care
Dr. Gabriella Bottari
Rome, Italy

We have applied CytoSorb in critical ill children with septic shock, with very good results.

Critical Care
Dr. Voyka Gorjup
Ljubljana, Slovenia

The most prominent clinical effect is the lowering of vasopressors, hemodynamic stability, lowering of interleukins and in those patients who are on vvECMO…

Critical Care
Dr. Candido Amador
Panama City, Panama

In my experience the vasopressor doses decreased, biomarkers of sepsis (…) and the inflammatory response as well as multiple organ function improved.

Cardiovascular
Dr. L. Christian Napp
Hannover, Germany

In the most critically ill patients on ECMO support, we observed a drop in catecholamine demand and an improvement in clinical state on ECMO.

Critical Care
Prof. Steffen Mitzner
Rostock, Germany

What strikes you first is that you can stabilize patients in septic shock.

Critical Care
Dr. Yatin Mehta
Gurgaon, India

CytoSorb is indicated for use in conditions where elevated levels of cytokine and/or bilirubin and/or myoglobin exist.